BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10965849)

  • 1. 8S-lipoxygenase products activate peroxisome proliferator-activated receptor alpha and induce differentiation in murine keratinocytes.
    Muga SJ; Thuillier P; Pavone A; Rundhaug JE; Boeglin WE; Jisaka M; Brash AR; Fischer SM
    Cell Growth Differ; 2000 Aug; 11(8):447-54. PubMed ID: 10965849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An antitumorigenic role for murine 8S-lipoxygenase in skin carcinogenesis.
    Kim E; Rundhaug JE; Benavides F; Yang P; Newman RA; Fischer SM
    Oncogene; 2005 Feb; 24(7):1174-87. PubMed ID: 15558016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.
    Shappell SB; Gupta RA; Manning S; Whitehead R; Boeglin WE; Schneider C; Case T; Price J; Jack GS; Wheeler TM; Matusik RJ; Brash AR; Dubois RN
    Cancer Res; 2001 Jan; 61(2):497-503. PubMed ID: 11212240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of peroxisome proliferator-activated receptor (PPAR)-mediated keratinocyte differentiation by lipoxygenase inhibitors.
    Thuillier P; Brash AR; Kehrer JP; Stimmel JB; Leesnitzer LM; Yang P; Newman RA; Fischer SM
    Biochem J; 2002 Sep; 366(Pt 3):901-10. PubMed ID: 12069687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gamma.
    Subbarayan V; Krieg P; Hsi LC; Kim J; Yang P; Sabichi AL; Llansa N; Mendoza G; Logothetis CJ; Newman RA; Lippman SM; Menter DG
    Oncogene; 2006 Sep; 25(44):6015-25. PubMed ID: 16682954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double dioxygenation by mouse 8S-lipoxygenase: specific formation of a potent peroxisome proliferator-activated receptor alpha agonist.
    Jisaka M; Iwanaga C; Takahashi N; Goto T; Kawada T; Yamamoto T; Ikeda I; Nishimura K; Nagaya T; Fushiki T; Yokota K
    Biochem Biophys Res Commun; 2005 Dec; 338(1):136-43. PubMed ID: 16112079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal lipoxygenase products of the hepoxilin pathway selectively activate the nuclear receptor PPARalpha.
    Yu Z; Schneider C; Boeglin WE; Brash AR
    Lipids; 2007 Jun; 42(6):491-7. PubMed ID: 17436029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
    Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
    Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of Musk T on peroxisome proliferator-activated receptor [PPAR]-alpha activation, epidermal skin homeostasis and dermal hyaluronic acid synthesis.
    Kim SH; Nam GW; Lee HK; Moon SJ; Chang IS
    Arch Dermatol Res; 2006 Nov; 298(6):273-82. PubMed ID: 16977445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding.
    Sugden MC; Bulmer K; Gibbons GF; Holness MJ
    Arch Biochem Biophys; 2001 Nov; 395(2):246-52. PubMed ID: 11697863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
    Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal differentiation and keratin gene expression.
    Fuchs E
    Princess Takamatsu Symp; 1994; 24():290-302. PubMed ID: 8983083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes.
    Tien ES; Gray JP; Peters JM; Vanden Heuvel JP
    Cancer Res; 2003 Sep; 63(18):5767-80. PubMed ID: 14522898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of epidermal tumor development caused by targeted overexpression of epidermis-type 12S-lipoxygenase.
    Müller K; Siebert M; Heidt M; Marks F; Krieg P; Fürstenberger G
    Cancer Res; 2002 Aug; 62(16):4610-6. PubMed ID: 12183416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-gamma, normalizes epidermal homeostasis in a murine hyperproliferative disease model.
    Demerjian M; Man MQ; Choi EH; Brown BE; Crumrine D; Chang S; Mauro T; Elias PM; Feingold KR
    Exp Dermatol; 2006 Mar; 15(3):154-60. PubMed ID: 16480422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of epidermis-type lipoxygenases for skin barrier function and adipocyte differentiation.
    Fürstenberger G; Epp N; Eckl KM; Hennies HC; Jørgensen C; Hallenborg P; Kristiansen K; Krieg P
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):128-34. PubMed ID: 17164140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
    Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
    Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous effect of ursolic acid and oleanolic acid on epidermal permeability barrier function and epidermal keratinocyte differentiation via peroxisome proliferator-activated receptor-alpha.
    Lim SW; Hong SP; Jeong SW; Kim B; Bak H; Ryoo HC; Lee SH; Ahn SK
    J Dermatol; 2007 Sep; 34(9):625-34. PubMed ID: 17727365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.
    Shipley JM; Waxman DJ
    Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.